Novanta (NOVT) Projected to Post Earnings on Tuesday

Key Points

• Novanta (NOVT) is set to announce its Q2 2025 earnings on Tuesday, August 5th, with analysts expecting earnings of $0.74 per share and revenue of $237.97 million.
• In its last earnings report on May 6th, Novanta surpassed analysts' expectations with a reported $0.74 EPS and a revenue increase of 1.1% year-over-year.
• Institutional investors hold 98.35% of Novanta's stock, indicating significant confidence in the company, despite a recent downgrade from a "buy" to a "hold" rating by Wall Street Zen.

Novanta (NASDAQ:NOVT - Get Free Report) is projected to issue its Q2 2025 quarterly earnings data before the market opens on Tuesday, August 5th. Analysts expect the company to announce earnings of $0.74 per share and revenue of $237.97 million for the quarter. Novanta has set its Q2 2025 guidance at 0.680-0.780 EPS.

Novanta (NASDAQ:NOVT - Get Free Report) last announced its quarterly earnings results on Tuesday, May 6th. The technology company reported $0.74 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.68 by $0.06. Novanta had a return on equity of 15.06% and a net margin of 7.42%. The business had revenue of $233.37 million for the quarter, compared to the consensus estimate of $233.34 million. During the same quarter last year, the business posted $0.74 EPS. The business's revenue was up 1.1% on a year-over-year basis. On average, analysts expect Novanta to post $3 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Novanta Stock Performance

Shares of NOVT stock traded down $0.58 during trading hours on Wednesday, reaching $123.24. The stock had a trading volume of 322,627 shares, compared to its average volume of 229,925. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.56 and a quick ratio of 1.70. The firm has a 50-day simple moving average of $126.04 and a 200-day simple moving average of $130.73. The firm has a market capitalization of $4.43 billion, a PE ratio of 62.88 and a beta of 1.45. Novanta has a twelve month low of $98.76 and a twelve month high of $186.75.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen downgraded Novanta from a "buy" rating to a "hold" rating in a research report on Saturday.

Hedge Funds Weigh In On Novanta

A number of institutional investors and hedge funds have recently bought and sold shares of NOVT. AQR Capital Management LLC boosted its holdings in shares of Novanta by 78.9% in the first quarter. AQR Capital Management LLC now owns 4,231 shares of the technology company's stock valued at $537,000 after acquiring an additional 1,866 shares in the last quarter. Goldman Sachs Group Inc. lifted its position in Novanta by 1.6% in the first quarter. Goldman Sachs Group Inc. now owns 419,037 shares of the technology company's stock worth $53,582,000 after purchasing an additional 6,533 shares during the period. Finally, Jane Street Group LLC boosted its stake in Novanta by 1,762.5% during the 1st quarter. Jane Street Group LLC now owns 61,631 shares of the technology company's stock valued at $7,881,000 after purchasing an additional 58,322 shares in the last quarter. Institutional investors own 98.35% of the company's stock.

Novanta Company Profile

Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.